Sep. 25, 2024 — Almost everyone knows about HIV. Fewer people know about its relative, HTLV-1. However, HTLV-1 can cause serious illnesses, including cancer. To develop ways to combat this virus ...

CTLT announces an agreement to sell its oral solids development and manufacturing facility in Somerset to Ardena.

The site also serves as an oral solids development and small-scale manufacturing facility for the pharmaceutical company, ...

Ardena inks agreement to acquire Catalent’s state-of-the-art facility in Somerset, New Jersey: Ghent, Belgium Tuesday, October 15, 2024, 16:00 Hrs [IST] Ardena, a specialist pha ...

Catalent entered into a definitive agreement to sell its oral solids development and small-scale manufacturing facility in ...

金吾财讯 | Catalent 已同意将其位于新泽西州萨默塞特的口服药物开发和小规模制造工厂出售给私人合同药品制造商 Ardena。 Catalent 为包括丹麦制药巨头诺和诺德的药物 Wegovy 在内的制药商提供合同制造服务并执行灌装工作，涉及注射器和注射笔的无菌灌装和包装。 拥有诺和诺德控股权的投资公司 Novo Holdings 于 2 月份签署了一项价值 165 亿美元的协议收购 Cat ...

合同制造服务提供商Catalent已达成协议，将其位于新泽西州萨默塞特的口服药物开发和小规模制造工厂出售给私人合同药品制造商Ardena。该交易于今日宣布。 这座获得美国食品和药物管理局(FDA)批准的萨默塞特工厂拥有约200名科学家和技术人员。Ardena表示，收购这座工厂将增强其在口服药物商业化生产方面的能力。 Catalent以其灌装完成工作而闻名，包括为制药公司进行注射器和注射笔的无菌灌装 ...

Awaiting a potential acquisition by Novo Holdings, Catalent is giving its contract manufacturing compatriot a boost as Ardena ...

Catalent, Inc. (CTLT), a provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer ...

Canton Fair has unveiled a new mobile app designed to enhance the convenience and efficiency of the event. This development is part of the organizer's aim to build an all-year-round Canton Fair and a ...

Novo Holdings is set to buy one less facility from Catalent as the manufacturer has sold a facility in New Jersey to a ...

Catalent has agreed to sell its oral drug development and small-scale manufacturing facility in Somerset, New Jersey to ...